You are here

SARC021 DOES NOT MEET ENDPOINT

Phase 3 study of evofasfamide with doxorubicin

This Threshold and SARC study for patients with advanced or metastatic STS did not show an improvement in survival. The results are disappointing. SARC is grateful for patients and physicians who participated.

Follow the link to review the Threshold News Release December 7, 2015.